Back to Trades
Hadar Ilan
Chairman and CEODirectorCIK 0001727727
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 1
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2026
Hadar Ilan, Chairman and CEO, Director, accounts for 1 disclosed filing worth $0, all concentrated in Silexion Therapeutics Corp (SLXN), active 2026. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
1 loaded
| Jun 8 | SLXN Silexion Therapeutics Corp | Hadar Ilan | Chairman and CEO, Director | Grant | $0 |
1 filing